Overview
Status
Active
Registry date
2017-06-23
Share capital
5,000.00 PLN
Registered address
ul. Dewajtis 5/438, 01-815 Warszawa, Poland
Financials
Revenue history
Filing timeliness
No financial statement for 2022 – the filing deadline has passed. 2 of 4 financial statements were filed late (the longest delay 269 days for 2020).
- 2022not filed
- 202126/07/2022
- 202011/07/2022
- 201913/07/2020
- 201826/06/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Agnieszka Dagmara Różycka – President of the Management Board
Dominik Zbigniew Wojewódka – Management Board Member
Manner of representation
In the case of a two-member management board, making declarations on behalf of the company requires joint action by two members of the management board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Agnieszka Dagmara Różyckaage 46 | 40 | $540.25 | 40% |
Krzysztof Maciej Różyckiage 50 | 40 | $540.25 | 40% |
| 20 | $270.12 | 20% |
Agnieszka Dagmara Różycka and Krzysztof Maciej Różycki hold a combined 80% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 23, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
FAQ
The main business activity of Biokumed focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on June 23, 2017.
The headquarters is located at: ul. Dewajtis 5, 01-815 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2021 to December 31, 2021.
Last updated: 2026-04-24